| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5618541 | Journal of Vascular Surgery | 2016 | 5 Pages |
Abstract
Reduction of GLO1 activity in atherosclerotic lesions of nondiabetic patients with increased HbA1c is associated with a functional involvement of this protective enzyme in atherogenesis. Systemic GLO1 activity seems to be independent of both HbA1c and localized atherosclerosis as it was unchanged between group I and group II as well as compared with healthy controls, respectively.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Andreas S. MD, Marieluise Lercher, Thomas H. PhD, Peter P. MD, Moritz S. MD, Susanne PhD, Dittmar MD, Maani MD,